Freshly Appointed Auspherix CEO Highlights New Antibiotic Class
Executive Summary
Dr Neil Miller, the recently-appointed CEO of UK-based biotech Auspherix, talks to Scrip about the company's new class of antibiotics and how it plans to help address the worldwide antimicrobial resistance crisis.